-
61
Radiographic Left Atrial Size Measurement of Dogs in Different Mitral Valve Disease Stages with Four Different Methods
Published 2023-12-01“…The left atrial size increases (LAS) in patients with mitral valve disease (MVD) as the disease progresses. The vertebral left atrial size (VLAS), the modified-vertebral left atrial size (M-VLAS), and the radiographic left atrial dimension (RLAD) are methods reported to assess LAS on dogs’ radiographs. …”
Get full text
Article -
62
Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve disease
Published 2023-07-01Subjects: Get full text
Article -
63
Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease
Published 2023-12-01“…Although it is well recognized that the typical symptoms of Myxomatous Mitral Valve Disease (MMVD) stage B2 are long-standing hemodynamic disorder and cardiac structure remodeling caused by mitral regurgitation, the transcriptomic alterations in blood from such dogs are not understood. …”
Get full text
Article -
64
Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C
Published 2022-12-01Subjects: Get full text
Article -
65
Association of Paraoxonase-1 and NT-proBNP with Clinical, Clinico-Pathologic and Echocardiographic Variables in Dogs with Mitral Valve Disease
Published 2023-01-01Subjects: “…mitral valve disease…”
Get full text
Article -
66
Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration
Published 2017-03-01“…Little is known about the relationship between myxomatous mitral valve disease (MMVD) and oxidative stress in dogs. …”
Get full text
Article -
67
Severe mixed mitral valve disease due to massive mitral annular calcification — a case report and literature review
Published 2022-05-01“…To our knowledge severe mixed mitral valve disease secondary to MAC is extremely rare. …”
Get full text
Article -
68
-
69
Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
Published 2020-09-01Subjects: Get full text
Article -
70
Evaluation of the corrected QT interval with Bazett’s Method in Cavalier King Charles Spaniel dogs with myxomatous mitral valve disease
Published 2023-03-01“…Myxomatous mitral valve disease (MMVD) is one of the most common heart diseases in dogs. …”
Get full text
Article -
71
Efficacy of a mitral regurgitation severity index to predict long‐term outcome in dogs with myxomatous mitral valve disease
Published 2024-01-01“…Abstract Background Predicting progression of myxomatous mitral valve disease (MMVD) in dogs can be challenging. Hypothesis/Objectives The mitral regurgitation severity index (MRSI) will predict time to congestive heart failure (CHF) and all‐cause death in dogs with MMVD. …”
Get full text
Article -
72
-
73
Real‐Time 3‐Dimensional Echocardiographic Assessment of Effective Regurgitant Orifice Area in Dogs With Myxomatous Mitral Valve Disease
Published 2017-03-01“…However, this simplified assumption only holds when the EROA is circular, which might not be true in dogs with myxomatous mitral valve disease (MMVD). Hypothesis Effective regurgitant orifice area in dogs with MMVD is noncircular, and using color Doppler real‐time 3‐dimensional (RT3D) echocardiography, measured EROA in the en face view will be significantly different from calculated EROA. …”
Get full text
Article -
74
-
75
The Thoracic Inlet Length as a Reference Point to Radiographically Assess Cardiac Enlargement in Dogs with Myxomatous Mitral Valve Disease
Published 2023-08-01Subjects: Get full text
Article -
76
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease
Published 2022-11-01“…Abstract Background Dogs with myxomatous mitral valve disease (MMVD) can experience progressive renal tubular damage and dysfunction. …”
Get full text
Article -
77
-
78
Machine learning-based risk prediction model for canine myxomatous mitral valve disease using electronic health record data
Published 2023-08-01“…IntroductionMyxomatous mitral valve disease (MMVD) is the most common cause of heart failure in dogs, and assessing the risk of heart failure in dogs with MMVD is often challenging. …”
Get full text
Article -
79
Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
Published 2024-01-01“…In dogs with degenerative mitral valve disease (DMVD), pulmonary hypertension (PH) is a common complication characterized by abnormally elevated pulmonary arterial pressure (PAP). …”
Get full text
Article -
80
Endothelin-1 gene and endothelin receptor A gene polymorphisms in severe pulmonary hypertension associated with rheumatic mitral valve disease
Published 2022-01-01“…Introduction Endothelin-1 (ET-1) gene polymorphisms are implicated in pathogenesis of idiopathic pulmonary arterial hypertension Material and methods We studied ET-1 (Lys198Asn and 3A/4A) and endothelin receptor A (ETA) gene (His323His) polymorphisms in 123 subjects with pulmonary hypertension associated with rheumatic mitral valve disease (PH-MVD) and 123 healthy controls. …”
Get full text
Article